• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病非药物干预的研究与应用进展。

Progress of research and application of non-pharmacologic intervention in Alzheimer's disease.

机构信息

Ningbo Rehabilitation Hospital, Ningbo, Zhejiang, China.

The First People's Hospital of Wenling, Taizhou, Zhejiang, China.

出版信息

J Alzheimers Dis. 2024 Nov;102(2):275-294. doi: 10.1177/13872877241289396. Epub 2024 Oct 29.

DOI:10.1177/13872877241289396
PMID:39573867
Abstract

Alzheimer's disease (AD) is a common neurodegenerative disease characterized by amyloid-β (Aβ) deposition and neurofibrillary tangles formed by high phosphorylation of tau protein. At present, drug therapy is the main strategy of AD treatment, but its effects are limited to delaying or alleviating AD. Recently, non-pharmacologic intervention has attracted more attention, and more studies have confirmed that non-pharmacologic intervention in AD can improve the patient's cognitive function and quality of life. This paper summarizes the current non-pharmacologic intervention in AD, to provide useful supplementary means for AD intervention.

摘要

阿尔茨海默病(AD)是一种常见的神经退行性疾病,其特征是淀粉样蛋白-β(Aβ)沉积和由高磷酸化tau 蛋白形成的神经原纤维缠结。目前,药物治疗是 AD 治疗的主要策略,但效果仅限于延缓或缓解 AD。最近,非药物干预引起了更多关注,越来越多的研究证实 AD 的非药物干预可以改善患者的认知功能和生活质量。本文总结了 AD 的当前非药物干预措施,为 AD 的干预提供有用的补充手段。

相似文献

1
Progress of research and application of non-pharmacologic intervention in Alzheimer's disease.阿尔茨海默病非药物干预的研究与应用进展。
J Alzheimers Dis. 2024 Nov;102(2):275-294. doi: 10.1177/13872877241289396. Epub 2024 Oct 29.
2
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.阿尔茨海默病的最新研究进展:从基础研究到诊断和治疗。
Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.
3
Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APP/PS1 mice.长期高压氧治疗对 APP/PS1 小鼠阿尔茨海默病神经病理学和认知障碍的治疗效果。
Redox Biol. 2024 Apr;70:103006. doi: 10.1016/j.redox.2023.103006. Epub 2023 Dec 23.
4
[Recent progress in the development of disease-modifying therapies for Alzheimer's disease].[阿尔茨海默病疾病修饰疗法的研发进展]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Feb;30(1):1-8.
5
Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.通过定量蛋白质组学评估新型阿尔茨海默病小鼠模型中的分子和功能特征。
Mol Neurodegener. 2018 Jan 16;13(1):2. doi: 10.1186/s13024-017-0234-4.
6
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
7
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.突触线粒体:阿尔茨海默病中淀粉样β和tau 的早期靶标。
J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139.
8
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.可溶性纤维前体tau蛋白和β-淀粉样蛋白在早期人类阿尔茨海默病中出现,并与疾病进展和认知衰退相关。
Acta Neuropathol. 2016 Dec;132(6):875-895. doi: 10.1007/s00401-016-1632-3. Epub 2016 Oct 21.
9
Exploring the dual character of metformin in Alzheimer's disease.探索二甲双胍在阿尔茨海默病中的双重作用。
Neuropharmacology. 2022 Apr 1;207:108966. doi: 10.1016/j.neuropharm.2022.108966. Epub 2022 Jan 22.
10
Therapeutic potential of natural products against Alzheimer's disease via autophagic removal of Aβ.天然产物通过自噬清除 Aβ 对阿尔茨海默病的治疗潜力。
Brain Res Bull. 2024 Jan;206:110835. doi: 10.1016/j.brainresbull.2023.110835. Epub 2023 Dec 1.

引用本文的文献

1
Potential common pathogenesis of several neurodegenerative diseases.几种神经退行性疾病潜在的共同发病机制。
Neural Regen Res. 2026 Mar 1;21(3):972-988. doi: 10.4103/NRR.NRR-D-24-01054. Epub 2025 May 30.